Viewing Study NCT00559156


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-02-21 @ 1:02 PM
Study NCT ID: NCT00559156
Status: COMPLETED
Last Update Posted: 2025-02-13
First Post: 2007-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent squamous cell carcinoma of the hypopharynx View
None stage III squamous cell carcinoma of the hypopharynx View
None stage IV squamous cell carcinoma of the hypopharynx View
None stage III squamous cell carcinoma of the larynx View
None stage IV squamous cell carcinoma of the larynx View
None recurrent squamous cell carcinoma of the larynx View
None recurrent squamous cell carcinoma of the lip and oral cavity View
None stage III squamous cell carcinoma of the lip and oral … View
None stage IV squamous cell carcinoma of the lip and oral … View
None recurrent squamous cell carcinoma of the nasopharynx View
None stage III squamous cell carcinoma of the nasopharynx View
None stage IV squamous cell carcinoma of the nasopharynx View
None recurrent squamous cell carcinoma of the oropharynx View
None stage III squamous cell carcinoma of the oropharynx View
None stage IV squamous cell carcinoma of the oropharynx View
None recurrent salivary gland cancer View
None salivary gland squamous cell carcinoma View
None stage III salivary gland cancer View
None stage IV salivary gland cancer View